Hidden heterogeneity and its influence on dengue vaccination impact

The CYD-TDV vaccine was recently developed to combat dengue, a mosquito-borne viral disease that afflicts millions of people each year throughout the tropical and subtropical world. Its rollout has been complicated by recent findings that vaccinees with no prior exposure to dengue virus (DENV) exper...

Descripción completa

Detalles Bibliográficos
Autores principales: Walters, Magdalene, Perkins, T. Alex
Formato: Online Artículo Texto
Lenguaje:English
Publicado: KeAi Publishing 2020
Materias:
Vector-borne Disease Modelling; Edited by Dr. Patrick Leighton, Dr. Nicholas Ogden, Dr. Jianhong Wu
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7558830/
https://www.ncbi.nlm.nih.gov/pubmed/33102984
http://dx.doi.org/10.1016/j.idm.2020.09.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7558830/
https://www.ncbi.nlm.nih.gov/pubmed/33102984
http://dx.doi.org/10.1016/j.idm.2020.09.008

Ejemplares similares